SLN · NASDAQ · Biotechnology

Silence Therapeutics (ADR)

Develops liver-targeted siRNA medicines through its mRNAi GOLD platform.

$13.42
After-hours close−0.04 (−0.30%)
At close$13.46(+0.07%)
DateEstimateReportedSurprise
Nov 2026−$0.12
Aug 2026−$0.13−$0.26−104.4%
May 2026−$0.33−$0.32+3.0%
Mar 2026−$0.32−$0.25+21.9%
Nov 2025−$0.40−$0.45−12.5%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Feb 2025
Nov 2024
May 2024
Nov 2023
Aug 2023
May 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Jun 2021
Mar 2021
Mar 2021
Sep 2020
Jun 2020
Mar 2020
Dec 2019
Sep 2019
Jun 2019
Mar 2019
Dec 2018
Sep 2018
Jun 2018
Mar 2018
Dec 2017
Sep 2017
Jun 2017
Mar 2017
Dec 2016
Sep 2016
Jun 2016
Mar 2016
Dec 2015
Sep 2015
Jun 2015
Mar 2015
Dec 2014
Sep 2014
Jun 2014
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 5, 2026−$0.12$124.2K
Aug 10, 2026−$0.13−$0.26−104.4%$1.1M$137.2K−87.9%
May 7, 2026−$0.33−$0.32+3.0%$1.3M$422.0K−66.4%
Mar 5, 2026−$0.32−$0.25+21.9%$2.9M$39.0K−98.7%
Nov 6, 2025−$0.40−$0.45−12.5%$3.1M$159.0K−94.9%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 7, 2025
May 8, 2025
Feb 27, 2025
Nov 14, 2024
May 16, 2024
Nov 14, 2023
Aug 16, 2023
May 16, 2023
Nov 10, 2022
Aug 11, 2022
May 16, 2022
Mar 17, 2022
Jun 30, 2021
Mar 31, 2021
Mar 30, 2021
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019
Dec 31, 2018
Sep 30, 2018
Jun 30, 2018
Mar 31, 2018
Dec 31, 2017
Sep 30, 2017
Jun 30, 2017
Mar 31, 2017
Dec 31, 2016
Sep 30, 2016
Jun 30, 2016
Mar 31, 2016
Dec 31, 2015
Sep 30, 2015
Jun 30, 2015
Mar 31, 2015
Dec 31, 2014
Sep 30, 2014
Jun 30, 2014